finIO

Markets Brief

← All briefs

Hyperscaler Capex Outruns Cash Flow as SpaceX's First Public Report Lands Tuesday

Microsoft and Amazon delivered the cloud growth that rescued a brutal week for tech, but Amazon's $20bn capex increase and negative free cash flow define the sector's new financing problem.

August 2, 2026 Earnings

Microsoft: the AI capex return finally shows up in Azure

Microsoft's fiscal 2026 results (year ended June 30) answered the year's central bear case — that its capital spending would not convert into revenue — and the stock jumped 15% in a single day, leaving it up 27% from the 52-week low it hit on June 25 while still negative for the year. Azure revenue rose 41% year over year and crossed $100 billion in annual revenue for the first time; Microsoft Cloud rose 27% to over $214 billion; and the $678 billion cloud backlog grew 25% year over year even excluding OpenAI. The offsetting detail is the rest of the company: "more personal computing" revenue fell 4%, Xbox hardware dropped 13%, and Windows OEM/devices fell 7%.

Amazon: growth accelerating, funding unanswered

AWS grew 37% to $42.2 billion, beating the 31.2% expected and marking its fastest growth in 18 quarters, with Amazon's AI and chip businesses each past $25 billion in annualized run rate. But CEO Andy Jassy raised 2026 capital spending from $200 billion to $220 billion — explicitly because of soaring memory chip prices — and when asked how it would be funded said only, "Nothing to share today." Trailing-twelve-month free cash flow has swung to negative $7.6 billion from positive $18.2 billion a year earlier, after a planned $25 billion eight-tranche bond sale (maturities 2029 to 2066) and a $37 billion raise in March. Moody's puts sector capex at $785 billion in 2026 and near $1 trillion in 2027, with roughly $175 billion of hyperscaler debt issuance this year against a five-year average of $30 billion — the constraint is shifting from demand to balance sheets, with Jassy saying even $220 billion won't meet demand and that 2028 demand is already "striking."

SpaceX: first print, then the lockup

Tuesday's report is the first as a public company for the largest IPO in history, and the setup is unusually two-sided. Consensus looks for second-quarter revenue of $6.9 billion, up 68% year over year, with roughly 100% growth expected for both 2026 and 2027, taking 2027 revenue to $80 billion from $18.7 billion in 2025; Starlink grew revenue 50% in 2025, and the AI infrastructure business — $3.2 billion of revenue last year including X advertising — has signed compute deals with Anthropic and Alphabet. Two days after the print, on August 6, a large tranche of insider shares unlocks. With a $1.5 trillion market cap and shares already down 44% from highs, the supply event is the more mechanical of the two catalysts.

Lucid: a liquidity report, not a delivery report

Lucid reports Tuesday after the close with its market cap now below $3 billion, versus over $20 billion for Rivian and near $1 trillion for Tesla, after shedding a third of its value this year. The company reported $4.7 billion in liquidity last quarter — enough to survive into 2027 — but is trying to make the same pivot toward autonomy and robotaxis as its larger peers while also bringing two sub-$50,000 models to market, with first production expected late this year or early 2027. Saudi Arabia's Public Investment Fund owns most of the voting shares, so the terms of any further raise are not set by minority holders.

Elsewhere: consumer pressure and a mixed tape

Papa Murphy's will close 68 underperforming corporate-owned stores, CEO Eric Lefebvre said on the second-quarter call, with some closing as early as next week and the full program taking six to nine months against a base of more than 1,000 locations across 34 states. The category context matters more than the count: pizzerias have fallen to sixth place among American restaurant categories behind coffee shops and Mexican restaurants, restaurant counts have declined since 2019, and Nation's Restaurant News cites inflation, third-party delivery margin and data loss, and GLP-1 medications quietly pulling down portion sizes and order frequency. Elsewhere, Organon missed by $0.50 with revenue short of estimates, while Banco de Chile beat on both earnings and revenue.

Sources

Not investment advice.